A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma
- Status
- COMPLETED
- Phase
- N/A
A Study Comparing the Efficacy and Safety Between IBI308 and Docetaxel in Patients With Advanced or Metastatic NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Resistance & Activating Mutations Diagnosed Among NSCLC Community Dwelling EGFR Mutation Positive Patients
- Status
- COMPLETED
- Phase
- N/A
MAGE-A4ᶜ¹º³²T for Multi-Tumor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase I Study of a Selective ALK Inhibitor PLB1003 in Patients With ALK+ NSCLC.
- Status
- UNKNOWN
- Phase
- PHASE1
Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of the Correlation Between CRF, Survival and Physiological Factors in NSCLC Patients Under Chemotherapy
- Status
- UNKNOWN
- Phase
- N/A
An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer (TASUKI-52)
- Status
- COMPLETED
- Phase
- PHASE3
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
- Status
- COMPLETED
- Phase
- N/A
Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1/2 Trial of Selinexor (KPT-330) With Docetaxel for Non-small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Consolidation Pembrolizumab After Concurrent Chemotherapy and Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ceritinib + Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE1